From Sarepta Preps For Sales As Insurers Unlikely To Deny Duchenne Drug:

Kathryn Wagner

Kathryn Wagner—

Kathryn Wagner, director of the Kennedy Krieger Institute’s center for genetic muscle disorders.

Underwriters and Partners

Xpertise: Watch + Learn

Xconomy Insight · Special Report
Starting a Biotech Company: What Every Entrepreneur Needs to Know
Get advice from the experts to help your biotech startup succeed

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Facing an Uncertain Future
Xconomy

From Our Editors · Special Report
2019 Blockchain Outlook — Reality Check
Reality Check
Xconomy

From Our Advertisers

Wisconsin helps biotech company raise $20 million
See how TAI Diagnostics achieved accelerated growth
Wisconsin Economic Development Corporation

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

IDG Tech Network

Protected by Carbonite

Eventbrite - events made easy